Clinical Trials Logo

Verrucous Oral Leukoplakia clinical trials

View clinical trials related to Verrucous Oral Leukoplakia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03603223 Recruiting - Leukoplakia Clinical Trials

Pembrolizumab in Treating Participants With Leukoplakia

Start date: May 3, 2019
Phase: Phase 2
Study type: Interventional

This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.